In conclusion, positive CD25+/CD123+ positive coexpression defines a subset of B-ALL patients with poor outcome and could be helpful to refine the risk stratification of B-ALL cases at diagnosis. This evidence concerns the gene IL3RA and precursor B-cell acute lymphoblastic leukemia.